• A Case of Advanced Oral Submucous Fibrosis Management: Beyond Conventional Approach
• A clinic-pathological research explored the significance of ascorbic acid and iron levels in serum and saliva in premalignant disorder patients at Kanpur, Uttar Pradesh
• A Comparative Study of the Treatment of Oral Premalignant Lesions with Surgical Excision and Medical Therapy
• A conjugate vaccine strategy that induces protective immunity against arecoline
• A Retrospective Study Comparing the Surgical Results of Platysma Myocutaneous Flap, Buccal Pad of Fat, and Nasolabial Flap for Reconstruction After Fibrotomy in Cases of Oral Submucous Fibrosis
• A scientometric study on research trends and characteristics of oral submucous fibrosis
• Abdominal Dermal Fat Graft Versus Nasolabial Flap in Oral Submucous Fibrosis: A Randomized Clinical Trial
• Aberrantly downregulated FENDRR by arecoline elevates ROS and myofibroblast activation via mitigating the miR-214/MFN2 axis
• Adiponectin inhibits ROS/NLRP3 inflammatory pathway through FOXO3A to ameliorate oral submucosal fibrosis
• Alteration of salivary LPO, MDA, LDH, glutathione, GPx, SOD and vitamins in oral submucous fibrosis: A three-level meta-analysis study
• An enigmatic pathogenetic mechanism of hypoxia inducible factor - 1/2 alpha in the progression of fibrosis of oral submucous fibrosis and its malignant transformation: A systematic review and meta-analysis
• Analysis of salivary alpha-L-fucosidase and salic acid among oral sub-mucous fibrosis patients
• Anti-inflammatory and Antioxidant Activity of Cucumis sativus and Citrus macroptera Herbal Formulation: An In-Vitro Study
• Antifibrotic effect of silymarin on arecoline-induced fibrosis in primary human buccal fibroblasts: an in silico and in vitro analysis
• Areca nut-induced oral fibrosis - Reassessing the biology of oral submucous fibrosis
• Arecoline promotes fibroblast activation and M2-macrophage polarization by up-regulating the expression of IL-4
• Assessment of knowledge and awareness among North Indian populations about oral precancerous lesions (OPL): A cross-sectional survey study
• Association of Oral Submucous Fibrosis Risk with <em>GSTM1</em> and <em>GSTT1</em> Gene Polymorphisms
• Awareness of Oral Submucous Fibrosis among the Quid-Chewing South-Asian Expatriates in the United Arab Emirates
• Bilateral Tunnelized FAMM Islanded Flap for Reconstruction of Composite Defect of Tongue and Floor of Mouth: A Case Report
• Change and pathological significance of glycogen content in oral squamous cell carcinoma and oral submucous fibrosis
• circMTO1/miR-30c-5p/SOCS3 axis alleviates oral submucous fibrosis through inhibiting fibroblast-myofibroblast transition
• Clinical aspects of oral cancer and potentially malignant disorders in South and Southeast Asia
• Clinical Profile and Prevalence of Oral Mucosal Lesions in Tobacco Users-A Prospective Study from Jammu, India
• Comparative Analysis of Tissue Copper Levels in Oral Submucous Fibrosis (OSMF) Patients
• Comparative analysis of trace elements in the saliva and serum of patients with oral submucous fibrosis and squamous cell carcinoma
• Comparative assessment of the efficacy of an intralesional injection of placentrex, hyaluronidase and dexamethasone in the management of oral submucous fibrosis: A randomized controlled trial
• Comparative Evaluation of Plasma Fibrinogen Degradation Product and Salivary Fibrin Precipitating Factor in Oral Submucous Fibrosis Patients and Betel Quid Chewers
• Comparative evaluation of salivary, serum and urinary 8-OHdG in gutka-associated oral submucous fibrosis
• Comparing efficacy of curcumin with other treatment modalities in oral submucous fibrosis management - A systematic review and meta-analysis
• Computational analysis of phytocompounds in <em>Centella asiatica</em> for its antifibrotic and drug-likeness properties - Herb to drug study
• Correlation between Vascularity and Advancing Histological Grades of Oral Submucous Fibrosis with a Plausible Role in Malignisation: Systematic review of a persisting matter of conflict
• Development of Epigallocatechin 3-gallate-Loaded Hydrogel Nanocomposites for Oral Submucous Fibrosis
• Diseases with oral malignant potential: Need for change to inform research, policy, and practice
• DPSCs regulate epithelial-T cell interactions in oral submucous fibrosis
• Editorial: Oral mucosa and disorders: from drug discovery to development and translation
• Effect of Jiedu Huayu decoction on oral mucosal Axin and beta-catenin expression in oral submucosal fibrosis model rats
• Efficacy and Safety of Astaxanthin in the Management of Oral Submucous Fibrosis: A Preliminary Randomized Controlled Trial
• Efficacy of Oral Colchicine and Intralesional Hyaluronidase with and without Ultrasound Therapy in the Management of Oral Submucous Fibrosis-A Comparative Study
• Electromyography Analysis of the Masseter Muscle's Activity in the Management of Oral Submucous Fibrosis
• Elongated Styloid Process Evaluation Using Panoramic Radiography in Patients With Oral Submucous Fibrosis: A Retrospective Study
• Enhanced ZEB 1 stromal expression is a marker for epithelial mesenchymal transition in oral submucous fibrosis
• Enzyme-linked immunosorbent assay and immunohistochemical analysis of mast cell related biochemicals in oral submucous fibrosis
• Epidemiological Trends and Clinicopathological Characteristics of Oral Leukoplakia: A Retrospective Analysis From a Single Institution in Chennai, Tamil Nadu, India
• Estimation of depression, anxiety and serum cortisol in patients with oral lichen planus, leukoplakia and oral submucous fibrosis
• Evaluation of Platelet Parameters in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma in a Background of Oral Submucous Fibrosis
• Evaluation of possible role of fluoride in pathogenesis of oral submucous fibrosis: A pilot study
• Evaluation of salivary tumor necrosis factor alpha as a diagnostic biomarker in oral submucosal fibrosis and squamous cell carcinoma of the oral cavity and oropharynx: a cross sectional observational study
• Evaluation of stromal myofibroblasts in oral submucous fibrosis and its malignant transformation: An immunohistochemical study
• Evaluation of the non-endoscopic and endoscopic-assisted platysma flap - A randomized control trial
• Exosomal miR-17-5p derived from epithelial cells is involved in aberrant epithelium-fibroblast crosstalk and induces the development of oral submucosal fibrosis
• Expression of salivary levels of S100A7 in oral submucous fibrosis and oral leukoplakia
• Expression Profile of Circulating Exosomal microRNAs in Leukoplakia, Oral Submucous Fibrosis, and Combined Lesions of Leukoplakia and Oral Submucous Fibrosis
• Expression profile of diagnostic genes in oral submucous fibrosis
• Global and promoter specific hypermethylation of tumor suppressor genes P16, SOCS1, and SHP1 in oral squamous cell carcinoma and oral submucous fibrosis
• HLA-DQB1 Allele Polymorphism Associated with Oral Submucous Fibrosis in Hunan, China
• Immuno-histochemical evaluation of CD34 for OLP and OSMF
• Impact of tobacco habits on poor oral health status among bone-factory workers in a low literacy city in India: A cross-sectional study
• Initial intramuscular dissection as a rescue therapy during peroral endoscopic myotomy for achalasia patients with severe submucosal fibrosis
• Innovative Use of Mouth Props/Bite Blocks in Postoperative Mouth Opening Exercises
• Interventions for managing oral submucous fibrosis
• Knowledge About the Importance of Early Diagnosis and Treatment of Oral Potentially Malignant Disorders Among the South Indian Population: An Institutional Retrospective Study
• Lactate Dehydrogenase as a Biomarker in Oral Submucous Fibrosis: A Systematic Review and Meta-Analysis
• Langerhans cell expression in oral submucous fibrosis: An immunohistochemical analysis
• Lesion size affects the risk of technical difficulty in gastric endoscopic submucosal dissection
• Linking inflammation and angiogenesis with fibrogenesis: Expression of FXIIIA, MMP-9, and VEGF in oral submucous fibrosis
• Longitudinal outcomes of trismus release with free-flap reconstruction in primary and secondary oral submucous fibrosis-related trismus
• Mechanism of mangiferin in the treatment of oral submucous fibrosis based on Gene Expression Omnibus database chip mining combined with network pharmacology and molecular docking
• Mesenchymal stem cells in the management of oral submucous fibrosis-An enigma to be solved
• Novel role of CD34+ stromal cells/telocytes in oral submucous fibrosis development and its malignant transformation
• Oral Potentially Malignant Disorders and Oral Cancer in Saudi Arabia: An Epidemiological Review of the Literature
• Oral squamous cell carcinoma in the background of oral submucous fibrosis - a systematic review
• Oral submucosal fibrosis induced by active components in areca nut: a network pharmacology-based analysis and validation of the mechanism
• Oral submucous fibrosis: a guide to diagnosis and management
• Oral Submucous Fibrosis: a Premalignant Condition in a 22-Year-Old Iranian Man
• Oropharyngeal stenosis in patient with oral submucous fibrosis: a case report with 8-year follow-up
• Panax notoginseng saponins improve oral submucous fibrosis by inhabiting the Wnt/beta-catenin signal pathway
• PDE12 disrupts mitochondrial oxidative phosphorylation and mediates mitochondrial dysfunction to induce oral mucosal epithelial barrier damage in oral submucous fibrosis
• Prevalence and risk factors of oral potentially malignant disorders in Indonesia: a cross-sectional study undertaken in 5 provinces
• Repercussions of Smokeless Tobacco on Buccal Mucosa: A Community Based Observational Study at a Tertiary Care Centre in Western Rajasthan
• Resveratrol inhibits arecoline-induced fibrotic properties of buccal mucosal fibroblasts via miR-200a activation
• Role of Antioxidant Vitamins in Oral Submucous Fibrosis: A Narrative Review
• Role of osteopontin in oral epithelial dysplasia, oral submucous fibrosis and oral squamous cell carcinoma
• Role of Stem Cells in the Pathogenesis and Malignant Transformation of Oral Submucous Fibrosis
• Salivary and serum levels of lactate dehydrogenase in oral submucous fibrosis: A meta-analysis
• Salivary Profile in Oral Submucous Fibrosis: A Scoping Review
• Salivary transforming growth factor beta in oral submucous fibrosis: A diagnostic and predictive marker
• Serum and salivary interleukin-1beta level in oral precancer: An observational study
• Serum iron, zinc and copper among Indian patients with leukoplakia, oral submucous fibrosis and oral squamous cell carcinoma
• SFRP1 reduces neutrophil infiltration and inhibits the Wnt/beta-catenin pathway to alleviate oral submucous fibrosis
• Spatial Transcriptomic and Metabolomic Landscapes of Oral Submucous Fibrosis-Derived Oral Squamous Cell Carcinoma and its Tumor Microenvironment
• Stromal thrombospondin 1 suppresses angiogenesis in oral submucous fibrosis
• Targeting histone deacetylase 9 represses fibrogenic phenotypes in buccal mucosal fibroblasts with arecoline stimulation
• Targeting MetaLnc9/miR-143/FSCN1 axis inhibits oxidative stress and myofibroblast transdifferentiation in oral submucous fibrosis
• The association between betel quid use and oral potentially malignant and malignant disorders in Southeast Asian and Pacific regions: a systematic review and meta-analysis with GRADE evidence profile
• The interplay of EMT and stemness driving malignant transformation of Oral Submucous Fibrosis
• The Role and Significance of Trace Elements in Oral Submucosal Fibrosis
• Throat packing via nasopharyngeal airway for severe trismus cases requiring surgical intervention under general anesthesia: A simplified and innovative approach
• TUSC3, p53 and p21 genetic association with development of oral submucous fibrosis and oral squamous cell carcinoma among addictive tobacco chewers of Pakistan
• Up regulation of serum L fucose glycoprotein as a diagnostic biomarker for dysplasia in oral sub mucous fibrosis patients